We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Point-of-Care PGx Test Enables Rapid Appropriate Antiplatelet Prescription for Stroke Patients

By LabMedica International staff writers
Posted on 12 Jun 2025

Clopidogrel is an antiplatelet treatment for secondary prevention of minor strokes and transient ischemic attack (TIA), also known as a mini-stroke. More...

CYP2C19 intermediate and poor metabolizers who receive clopidogrel experience reduced platelet inhibition and increased risk for major adverse cardiovascular and cerebrovascular events. Pharmacogenetic testing assists prescribers in selecting tailored treatment and doses that are most effective and avoid those that may cause adverse reactions in an individual with a known genetic variant. This facilitates effective prescription in a clinically relevant timeframe, thereby improving patient outcomes. Now, a rapid point of care (POC) test for CYP2C19 genotyping can effectively guide antiplatelet therapeutics in time-critical settings.

The Genedrive CYP2C19 ID Kit from genedrive plc (Manchester, UK) provides rapid, automated results of CYP2C19 genotypes to inform clinicians on an individual’s metabolizer status according to CPIC guidelines in treatment strategies using therapeutics that are metabolized by CYP2C19. The Genedrive CYP2C19 ID Kit is the only POC genetic test to aid clinicians’ therapeutic treatment decisions for drugs that are metabolized by CYP2C19, and that are specifically affected by DNA variant alleles 2, 3, 4, 8, 17, and 35.

The test provides rapid, actionable results in approximately 69 minutes, including diplotype and CPIC-coded metabolizer status, enabling personalized treatment for antiplatelet therapies. The non-invasive test uses a single buccal swab and has a simple-to-follow workflow. The Genedrive CYP2C19 ID Kit is used in conjunction with the Genedrive System, featuring a compact benchtop design that allows it to be placed at the POC. Designed to be used in time-critical situations, before treatment prescription, it uses gene detection technology​ to provide automated and easy-to-interpret actionable results.

Related Links:
genedrive plc


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated PCR Setup
ESTREAM
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more

Pathology

view channel
Image: A tool uses artificial intelligence and high-resolution imaging to track senescent cells (Courtesy of Adobe Stock)

AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease

Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.